Johns Hopkins Singapore International Medical Centre is a 30-bed licensed medical oncology facility located in Tan Tock Seng Hospital. The facility, a joint venture between the National Healthcare Group (NHG) of Singapore and Johns Hopkins Medicine International (JHMI) is the only jointly owned and managed Johns Hopkins facility outside of the United States.
First opened in 2000 as a state-of-the-art oncology medical centre within the National University Hospital, Johns Hopkins Singapore International Medical Centre shifted to Tan Tock Seng Hospital in 2005.
Our major efforts in patient care and service focus are on solid tumors in breast, lung, gastric, colon, liver, nasopharyngeal and prostate cancers. In addition to cancer treatment, we work in collaboration with researchers from Johns Hopkins in Baltimore to develop novel therapies for diseases prevalent in the Asian region.
Our Services
Johns Hopkins Singapore International Medical Centre's services include:
- inpatient care at a private oncology ward,
- outpatient consultations and chemotherapy,
- internal medicine consultations and executive health screenings, as well as second opinions on complex medical conditions and consultations with referring physicians for specialty services.
You may be interested to read about
Oncology Specialists
